The endothelin system as target for therapeutic interventions in cardiovascular and renal disease
- 6 March 2020
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 506, 92-106
- https://doi.org/10.1016/j.cca.2020.03.008
Abstract
No abstract availableKeywords
Funding Information
- Karolinska Institutet
- Turkish Society of Nephrology
This publication has 151 references indexed in Scilit:
- The Vascular Endothelium and Human DiseasesInternational Journal of Biological Sciences, 2013
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic NephropathyJournal of the American Society of Nephrology, 2011
- Regulation of Blood Pressure and Salt Homeostasis by EndothelinPhysiological Reviews, 2011
- Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early AtherosclerosisCirculation, 2010
- Endothelin-1 Role in Human Eye: A ReviewJournal of Ophthalmology, 2010
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2009
- Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patientsProteomics – Clinical Applications, 2008
- Clinical trials of endothelin antagonists in heart failure: publication is good for the public healthHeart, 2007
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980